Search Results 331-340 of 10126 for SC

  1. Publications - Charles L. Loprinzi, M.D. - Mayo Clinic

    ... SC, Kumarakulasinghe N, Lim J, Sundar R. Safety and feasibility of concomitant scalp cooling and limb cryocompression to prevent paclitaxel-induced alopecia ...

  2. Get Started - Mayo Clinic

    This content does not have an Arabic version. Skip to content. Mayo ... SC: Mayo Clinic Breadcrumb. Home · Complex Care Program. Sections Complex Care ...

  3. Mayo Clinic in Florida

    The #1 hospital in Florida according to U.S. News & World Report 2023-2024. At Mayo Clinic in Florida, world-class providers and dedicated volunteers help ...

  4. Publications - Kevin C. Halling, M.D., Ph.D. - Mayo Clinic

    Gonzalez-Bosquet J, Shahi M, Yadav S, Kanwar N, Alvand S, Sosa C, Dowdy SC, Halling KC, Weroha SJ, Bakkum-Gamez JN, Podratz KC. ECPPF stratification ...

  5. Seborrheic dermatitis - Symptoms and causes - Mayo Clinic

    Find out what you can do to treat this flaky skin condition that can cause scaly skin and stubborn, itchy dandruff.

  6. Typhoid vaccine, inactivated (subcutaneous route, injection route) - Mayo Clinic

    Typhoid fever is a serious disease that can cause death. It is caused by a germ called Salmonella typhi and is spread most often through infected food or water.

  7. Saurabh Chhabra, M.B.B.S. - Doctors and Medical Staff - Mayo Clinic

    ... South Carolina. 2014 - 2016. DirectorPlasma Cell Disorders Clinic, Medical University of South Carolina. 2014 - 2016. Associate DirectorHematology/Oncology ...

  8. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

    About this study. The purpose of this trial is to evaluate the effectiveness, safety, and tolerability of subcutaneous (s.c.) ianalumab given every 4 weeks ...

  9. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

    The purpose of this study is to obtain long term safety and tolerability data of vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative ...

  10. Publications - Jing Qian, Ph.D. - Mayo Clinic

    Epub 2024 Mar 08. View PubMed; Madhavan S, Gamez M, Garces YI, Lester SC, Ma DJ, Mundy DW, Neben Wittich MA, Qian J, Routman DM, Foote RL, Shiraishi S.